Literature DB >> 9643057

Scaling of movement velocity: a measure of neuromotor retardation in individuals with psychopathology.

M P Caligiuri1, J B Lohr, R K Ruck.   

Abstract

The study of motor slowness based on observational methods has limitations. Whether motor retardation has a psychomotor or neuromotor basis is unclear because psychiatric and motor symptoms overlap. Observational methods lack the precision necessary to distinguish cognitive from motor processes. For the present study, we used an objective measure of neuromotor dysfunction to quantify the extent to which an individual programs movement velocity in anticipation of increasing target distance. Persons with Parkinson's disease (PD) or functional psychosis were studied with a group of healthy comparison subjects. Results indicated that the slope of the linear function relating velocity to distance was abnormal in the PD group and in approximately half of the psychosis group. Analyses revealed the measure to have high specificity and sensitivity. Weak correlations between velocity scaling and psychopathology support the neuromotor basis of the measure. We conclude that this measure of velocity scaling is relatively uninfluenced by cognitive factors that may underlie psychomotor retardation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9643057

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  9 in total

1.  The rate of force development scaling factor (RFD-SF): protocol, reliability, and muscle comparisons.

Authors:  Maria Bellumori; Slobodan Jaric; Christopher A Knight
Journal:  Exp Brain Res       Date:  2011-06-09       Impact factor: 1.972

2.  Extrapyramidal examinations in psychiatry.

Authors:  Richard D Sanders; Paulette Marie Gillig
Journal:  Innov Clin Neurosci       Date:  2012-07

3.  Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics.

Authors:  Michael P Caligiuri; Hans-Leo Teulings; Charles E Dean; Alexander B Niculescu; James B Lohr
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

4.  Haloperidol 2 mg impairs inhibition but not visuospatial attention.

Authors:  H N Alexander Logemann; Koen B E Böcker; Peter K H Deschamps; Peter N van Harten; Jeroen Koning; Chantal Kemner; Zsófia Logemann-Molnár; J Leon Kenemans
Journal:  Psychopharmacology (Berl)       Date:  2016-10-17       Impact factor: 4.530

5.  Quantitative assessment of motor abnormalities in untreated patients with major depressive disorder.

Authors:  James B Lohr; Todd May; Michael P Caligiuri
Journal:  J Affect Disord       Date:  2012-09-15       Impact factor: 4.839

6.  Motor Disturbance in ASD: A Pilot Study Showing Hypokinetic Behavior?

Authors:  M A L Mostert-Kerckhoffs; A E Willems; D E Tenback; J P Koning; P Van Harten; W G Staal
Journal:  J Autism Dev Disord       Date:  2020-02

Review 7.  The rate of force development scaling factor: a review of underlying factors, assessment methods and potential for practical applications.

Authors:  Žiga Kozinc; Darjan Smajla; Nejc Šarabon
Journal:  Eur J Appl Physiol       Date:  2022-01-19       Impact factor: 3.078

8.  An Instrumental Measure of Hand and Facial Movement Abnormalities in Patients With Schizophrenia.

Authors:  Shu-Mei Wang; Wen-Chen Ouyang; Hsiao-Man Hsu; Li-Ta Hsu
Journal:  Front Psychiatry       Date:  2022-03-04       Impact factor: 4.157

9.  Spontaneous parkinsonisms and striatal impairment in neuroleptic free youth at ultrahigh risk for psychosis.

Authors:  Derek J Dean; Vijay A Mittal
Journal:  NPJ Schizophr       Date:  2015-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.